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Abstract
Background: Health care services must engage all relevant healthcare workers, including nurses, in optimal
antimicrobial use to address the global threat of drug-resistant infections. Reflecting upon the variety of
antimicrobial stewardship (AMS) nursing models already implemented in the UK could facilitate policymaking and
decisions in other settings about context-sensitive, pragmatic nurse roles.
Methods: We describe purposefully selected cases drawn from the UK network of public sector nurses in AMS
exploring their characteristics, influence, relations with clinical and financial structures, and role content.
Results: AMS nursing has been deployed in the UK within ‘vertical’, ‘horizontal’ or ‘hybrid’ models. The ‘vertical’
model refers to a novel, often unique consultant-type role ideally suited to transform organisational practice by
legitimising nurse participation in antimicrobial decisions. Such organisational improvements may not be
straightforward, though, due to scalability issues. The ‘horizontal’ model can foster coordinated efforts to increase
optimal AMS behaviours in all nurses around a narrative of patient safety and quality. Such model may be unable
to address tensions between the required institutional response to sepsis and the inappropriate use of antibiotics.
Finally, the ‘hybrid’ model would increase AMS responsibilities for all nurses whilst allocating some expanded AMS
skills to existing teams of specialists such as sepsis or vascular access nurses. This model can generate economies
of scale, yet it may be threatened by a lack of clarity about a nurse-relevant vision.
Conclusions: A variety of models articulating the participation of nurses in antimicrobial stewardship efforts have
already been implemented in public sector organisations in the UK. The strengths and weaknesses of each model
need considering before implementation in other settings and healthcare systems, including precise metrics of
success and careful consideration of context-sensitive, resource dependent and pragmatic solutions.
Keywords: Antimicrobial stewardship, Nursing, Service delivery, Implementation
Background
Responding to the global threat of drug-resistant infections
(DRIs) demands a blend of wide-ranging yet integrated
technical and organisational approaches. Some of these ap-
proaches include clinical practice improvements, education
and training, surveillance, research and policy [1].
Such response to DRIs, however, must also overcome
some workforce dilemmas and challenges. On the one
hand, there have been proposals for governments,
healthcare leaders and other relevant actors to increase
funds and boost the number of frontline professionals
involved in relevant actions against drug resistance [2].
Alas, the current supply of healthcare professionals
worldwide is not robust enough to meet such demands,
with shortages of healthcare workers estimated to reach
~ 13 million by 2035 [3]. In the UK alone, for example,
more than 40,000 nursing positions remain vacant. There-
fore, it remains crucial to maximise the contribution of
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existing professional cadres towards appropriate use of
antimicrobials.
Among these cadres, nurses represent the largest
workforce worldwide. In India, for example, there were
just under 4 million nurses in 2016 [4], compared with
the 2.95 million nurses practising in the US [5], or the
287,000 full-time equivalent nurses and health visitors in
the UK at the end of 2017 [6]. Arguably, any marginal
gain –say, 1%– in the involvement of nurses across opti-
mal management of antibiotics to their full clinical and
leadership potential might have a compounded beneficial
effect for health services and patients. Such benefits
would be particularly welcomed in settings where scar-
city of human resources is most acute and the struggle
to establish ‘more traditional’ AMS teams (i.e., those
formed by a physician and a pharmacist) more pressing.
Endorsements for the integration or leadership of nurses
within AMS interventions have already been made [7, 8];
however, the majority of authors and position statements
published have sketched such participation primarily
around bedside, clinical, assistive and task-oriented anti-
microbial management. Those aspects, although relevant
and appropriate, still omit nurses from the wider decision-
making and executive process and therefore constrain
their potential influence and leadership on relevant anti-
microbial outcomes [9].
The drivers for such limiting perspective may be mul-
tiple, from perceptions within nursing and other health-
care professions about AMS as a mere technical process
requiring increased knowledge about antibiotic prescrip-
tions [10] and which therefore broadly excludes profes-
sionals without prescribing powers, to existing gaps in
undergraduate and postgraduate education about AMS
and resistance across human health disciplines [11, 12].
Gradually, though, a variety of interventions such as
the standardisation of educational competencies [13, 14]
(Table 1) and the regulation of professional AMS tasks
[15, 16] –both aspects crucial considering that effective
and sustainable AMS programs demand coordinated
efforts from multiple professional groups– have endea-
voured to close those gaps and balance their impact.
The maturity now reached by the notion of nurse par-
ticipation in AMS has also been reflected in some of the
new domains emerging for such participation, ranging
from leadership [17], political advocacy [18], or funding
of services [19]. (Fig. 1) This progressive inclusion of
nurses onto stewardship therefore presents a good op-
portunity to reflect upon some of the models of AMS
nursing already implemented, with a view to facilitate
efforts by healthcare workers and decision-makers con-
sidering the introduction or expansion of efforts.
Methods
The paper uses information from purposefully selected,
convenience cases drawn from the nationwide network of
public sector nurses in AMS in the UK exploring their sa-
lient characteristics, strategic influence, managerial and fi-
nancial relations with other structures, role content and
effect on professional identity. The cases were selected to
ensure sufficiently rich and contrasting information on
their characteristics was obtained, from London/outside
London healthcare services, urban and rural organisations,
reference and district hospitals, and role components. The
cases would help reflect upon lessons and propose models
that could be applicable internationally, thus facilitating
the implementation of context-sensitive and pragmatic
nurse roles.
The network, akin to a special interest group or a
community of practice [20], formed organically following
the 1st nursing summit in AMS held at Imperial College
London in the UK in January 2017. The network cur-
rently includes 109 nurses interested in progressing clin-
ical, academic, managerial and educational aspects of
nurse involvement in AMS, establishing mechanisms of
support for new entrants to the field, fostering collabora-
tions and ultimately encouraging professional visibility at
a time of calls for increased nursing leadership in the
area [21]. The network has received robust support from
clinical and research leaders from pharmacy and medi-
cine. Although the majority of members are based in the
UK, there are also professionals from Sweden, Australia,
Norway, South Africa, Nigeria and the Netherlands.
The information provided on enrolment to the network
by purposively selected cases was mapped against role
specifications, scope of practice, governance and organisa-
tional profiles (Table 2), with attention to how closely the
nurse roles resembled those previously introduced among
physicians and pharmacists [22], the setting of jurisdiction
and practice for the nurses (community, hospital, acute,
long-term care …), the organisational placing of the role
(i.e., whether embedded in infection prevention and con-
trol or antimicrobial stewardship pharmacy teams), spe-
cific role components (i.e., clinical, educational, quality or
service improvement, policy-making, managerial), and
measures of role process and outcome evaluation (that is,
which indicators would deem the roles as successful).
Table 1 Proposed antimicrobial stewardship education domains
for undergraduate students in healthcare disciplines in the
United Kingdom, [13]
Domain One: Infection prevention and control
Domain Two: Antimicrobials and antimicrobial resistance
Domain Three: The diagnosis of infection and the use of antimicrobials
Domain Four: Antimicrobial prescribing practice
Domain Five: Person centred care
Domain Six: Interprofessional collaborative practice
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Results
Nursing involvement and participation in stewardship
has adopted three broad yet distinct models (Table 3), in
close alignment with other clinical areas where innova-
tive roles and competencies have appeared [23–26].
‘Vertical’ model
Within this model, the participation of nurses in AMS
efforts would be channelled via the implementation of a
consultant nurse or advanced nurse practitioner role in
AMS. The focus of this novel and often unique position
would be AMS. In the UK, ‘consultant nurse’ roles were
introduced 20 years ago structured around four core
functions of expert practice of high autonomy; educa-
tion, training and development; professional leadership
to motivate others; service development, research and
evaluation [27].
Due to these characteristics and aspirations, the roles
may be ideal to transform organisational AMS practice.
Beyond the creation or commissioning of the post,
however, the overall structures for involvement and de-
livery of nursing input on stewardship would not be
transformed at large and any clinical effect or improve-
ment achieved stems from this expert, highly-specialised
and influential individual [28].
The appointment of such figure would demonstrate
organisational commitment and endorsement to im-
proved AMS performance, and galvanise and rationalise
efforts in AMS. Further, the introduction of this focal
person in a position of decision-making and influence
may legitimise the participation of nurses in AMS, in
particular if the main remit of the role is designing, im-
proving or leading practice. Without such guiding figure
it may be challenging for nurses to engage in effective
AMS, as seen in other areas such as infection prevention
and control [29]. As this model would replicate organ-
isational structures existing in other health professions
involved in AMS decisions and management, integration
within current clinical responsibilities and engagement
of other professionals may be easier.
Potentially, though, generating hard evidence of posi-
tive outcomes or benefits achieved by the introduction
of a single role or individual may be difficult. For ex-
ample, consultant nurses have so far made their greatest
impact in practice and service development and as
knowledge brokers [30], rather than in direct patient
outcomes and cost-benefit [31] thus being much more
challenging to demonstrate such impact when any effect
is achieved through the work of others. In antimicrobial
decision-making, though, the emerging importance of
behaviours such as persuading prescribers together with
the social dynamics that end up shaping prescriptions
has been gradually recognised [32], offering an ideal tar-
get for such advisory and influencing role. This also
seems to have been the case with Consultant Pharma-
cists in Infection and AMR in the UK, encouraging the
learning from previous experiences and across disci-
plines [33].
This hypothetical bottleneck in the translation from
role to benefits could also hamper the scalability of the
Fig. 1 Suggested roles and responsibilities for medical, pharmacy, and nursing staff as part of a stewardship team (adapted from [19])
Table 2 Domains of antimicrobial stewardship nursing model
analysis
Interprofessional working: Considers whether interprofessional working
(working with and across professions) is required for the role within the
model.
Strategic influence and relation with other structures, teams or services:
Defines the likely influence of the model at strategic and organisational
level, as well as the position of role holders in relation to other
organisational or professional structures.
Clinical outcomes: Describes whether changes resulting from
introduction of model would reflect impact or process achievements.
Individual identity: Examines the role archetype used within the
antimicrobial stewardship nursing model (i.e. consultant nurse-type, spe-
cialist nurse-type, or staff nurse-type).
Funding/Managerial structures: Describes managerial and supervisory
responsibility for nurses, as well as the kind of funding (pilot, short-term,
etc. …) and accountability for appointing the workers.
Setting of practice: Hospital, community, long-term care, nursing home
facilities …
Role components: Includes clinical, educational, quality improvement,
policy, and managerial components.
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model and affect assumptions underpinning economic
evaluations in view of the substantial start-up, upfront
implementation costs required (i.e., setting up the role
could be expensive) before realising any gains on AMS
outcomes. Regarding expenditures, decision-makers may
wish to account for any opportunity costs and avoid in-
efficiencies by reducing or eliminating potential overlap-
ping areas with other professionals.
Finally, there could be a danger of reinforcing multi- but
not inter-disciplinarity, by fostering parallel professional
lines where a nurse, for example, would address and engage
with nursing practices, whilst other professionals supervise
and support their own cadres, in tune with existing evi-
dence about social and team demarcations in antimicrobial
prescribing [34]. To mitigate such fragmentation, a priori
efforts would be vital to identify boundaries and relations
between the spheres of responsibility and influence of the
new role and others, for example between infection preven-
tion and control, or specialist sepsis nurses [35].
‘Horizontal’ model
Within this approach there would not be any specific or
dedicated AMS nurse role implemented. Instead, the or-
ganisation would engage in a concerted drive to increase
optimal AMS behaviours and practices among nurses.
Such behaviours may reflect nationally agreed objectives
[36] (Table 4), or conform to local needs.
This institutional perspective may serve to distance
AMS from the point of prescription or decision-making
about prescribing to a broader panoply of tasks, behav-
iours and decisions framed around the idea of providing
excellent care. Doing so would address the recognised
chasm between the awareness about AMS, a label hardly
recognised by nurses [37], and many clinical tasks per-
formed routinely – for example, ensuring that adequate
and biological samples are sent on time for analysis, ad-
ministering antibiotics doses on time, or communicating
to the multidisciplinary team clinical improvements in the
patient’s condition so alternative, less invasive therapy can
Table 3 Characteristics of antimicrobial stewardship nursing models
Domains
Antimicrobial
stewardship
nursing
model
Interprofessional
working
Strategic influence-
Relation with other
structures
Clinical outcomes
(What measure of
impact? Process?)
Individual identity Funding/
Managerial
structures
Setting of
practice
(hospital,
community
…)
Role
components
(clinical,
educational,
quality, policy,
managerial)
Vertical
(i.e. nurse
consultant)
Yes High strategic
influence; focal
relation with
comparable figures/
roles within own
profession (i.e. nurse
consultant) or others
(i.e. pharmacy
consultant);
collaboration/
leadership across
aligned areas (i.e.
AMS & IPC/AMS &
sepsis etc)
May be difficult to
robustly attribute
impact or clinical
improvements to
the role in view of
indirect work (i.e.
influencing others)
Feasible to
attribute process
improvements
Novel professional
figure/role,
supported by
similar professionals
in other clinical
areas, or
professionals from
other disciplines
Mainstream
human resources
funding
May be difficult
to evaluate value-
for-money
Appointed by
board-level
managers from
own or other
professions
Hospital or
community,
but most
likely
hospital
All, with
emphasis on
planning/
evaluation/
management
of
organisational
practice
Hybrid
(i.e. nurse
specialist)
Yes Some strategic
influence as part of
specialist services;
advisory relation with
own and other
professions across
multiple areas
Easy to attribute
impact or clinical
improvements
due to focus on
planning and
delivery of clinical
services,
education.
Traditional role with
some expanded or
novel skills/
responsibilities
which may have
been jurisdiction of
other professionals
or disciplines
Funding may be
short-term or pilot
before substantive,
based on results.
Appointed by
manager or lead
of specialist team,
which may not
be a nurse (i.e.
consultant
pharmacist or
physician in AMS)
Hospital or
community
All, with
mixture of
planning,
evaluation
and delivery
of services
Horizontal
(i.e. staff
nurse)
No Limited or minimal
strategic influence;
most relations within
own ward/team, with
frequent contact
with specialist/
advisory roles (i.e. IPC
specialists)
Feasible to
attribute impact
or clinical
improvements in
antimicrobial
stewardship
interventions
deployed
Traditional role,
supported by
similar professionals
in same or other
clinicals areas
Mainstream
human resources
funding.
Appointed by
ward manager/
nurse in charge
Hospital or
community
Mainly clinical,
educational,
quality and
managerial
service
delivery
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be considered or stopped–, which account for most ele-
ments embedded in AMS and are central to quality care.
Such point of view may also facilitate constructing a
meaningful and engaging narrative for nurses, who may
be much more receptive to messages framed around pa-
tient safety and quality than prescribing [38].
A great strength of this model would lie on its scalabil-
ity and potential size and speed of its impact. For
example, protocols and directives reflecting centrally-
driven priorities about antimicrobial performance may
be adopted with relative ease and therefore transform
clinical practice without delay [39, 40]. In reality, such
mandates tend to be met with organisational friction
which undermines their effect, unless there is an ad-
equate allocation of resources and responsibilities for
one or several individuals in charge of the design, imple-
mentation, adoption and evaluation of these AMS tasks
and responsibilities across the organisation and the nurs-
ing workforce [41] (Table 5).
In addition to the organisational friction, the horizontal
model may have difficulties resolving competing tensions
between existing paradigms within current antimicrobial
management, with the response to sepsis demanding swift
use of antibiotics whilst stewardship warrants a judicious,
perhaps more measured, approach. Without a focal nurs-
ing figure establishing an integrative vision that recognises
optimal use as the key behaviour (that is, prompt when
needed yet promptly reviewed to determine whether its
need remains relevant), nurses may not be able to engage
in such nuanced performance.
‘Hybrid model’ (vertical-horizontal)
Within this model, organisations would foster and im-
plement expectations about increased AMS tasks, roles,
responsibilities embedded within the remit of all clini-
cians including nurses, underpinning such expectations
with the allocation to existing healthcare workers of
some expanded or specialist AMS skills. This approach
could benefit from enhancing existing roles, such as in-
fection prevention and control link nurses, or including
further skills and responsibilities within existing special-
ist nursing teams – sepsis specialist nurses, or nurses in
vascular access team would appear particularly well
placed to embrace these additional responsibilities.
Other posts such as ward managers could combine their
leadership in infection prevention and control with an
emphasis on stewardship.
This model would offer benefits due to the economies
of scale derived from the use of a sizeable portion of the
workforce, and natural links with existing roles. How-
ever, such rewards may stall due to a lack of clarity
about a nurse-relevant vision to drive continued im-
provement, compounded by an increased complexity of
the management of drug-resistant infections.
Discussion
The broadening and expansion of nursing posts in AMS
could strengthen existing programs [42]. However, the
mere introduction of any roles –even if coupled with the
development of associated educational competencies–
may not be sufficient to stimulate benefits to patients,
organisations and the wider healthcare economy.
A crucial aspect to realise these benefits would be the
substantiation of clear, concrete, and precise markers of
success for such nursing participation, ideally concerned
about impact or outcomes rather than just process, in line
with the current debate about optimal antimicrobial pre-
scribing, for example [43, 44]. The challenges highlighted
in the recent CDC/ANA White Paper [45] related to the
existing absence of metrics that could reflect the benefit of
incorporating nurses onto service delivery structures has
to be acknowledged, and should encourage reflection at
the local and national level, depending on the needs and
resources available. Recent AMS experiences reported in
rural and remote areas in Australia [46] validate the acute
need to tailor interventions to the local context.
Although comparable analyses of AMS nursing models
in the UK or elsewhere are lacking, it would be possible
to apply our findings to some of the existing literature
describing the relation of nurses with existing AMS in-
terventions. For example, in their survey exploring the
participation of nurses in stewardship across the African
continent Bulabula et al. (2018) [47] advocate for
expanding the role of clinical nurses to support steward-
ship, particularly in rural areas, an idea that aligns com-
pletely with the horizontal model of wide addition of
skills and knowledge to the existing workforce. Further,
these authors recognise how existing IPC nurses may
also already attend AMS committees and input on policy
and clinical decisions, a scenario fitting to our hybrid
model of practice. Another example of such hybrid
Table 4 Components of ‘Start Smart then Focus’, [36]
- Do not start antibiotics in the absence of clinical evidence of bacterial
infection.
- For antibiotic(s) prescribed, document on drug chart and clinical notes:
indication (including disease severity if appropriate), dose, route and
duration or review date.
- Obtain cultures first where possible.
- Prescribe single dose antibiotics for surgical prophylaxis.
- Review clinical diagnosis and continuing need for antibiotics by 48–72
h and make a clear plan of action - the ‘antimicrobial prescribing
decision’.
- The five ‘antimicrobial prescribing decision’ options are Stop, Switch,
Change, Continue and OPAT.
- It is essential that the review and subsequent decision be clearly
documented in the clinical notes. The decision should also be
documented clearly on the drug chart.
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practice appears in a qualitative study conducted in the
US [48] documenting the engagement of nurses in opti-
mising the use of antibiotics in intensive care units. The
authors propose that existing advanced nurse practi-
tioners embrace AMS leadership roles, so the involve-
ment of other nursing colleagues is galvanized and
sustained.
Within the UK network the appointment of single
professionals on short, fixed-term contracts could be of
concern and raise doubts about the likelihood of achiev-
ing meaningful clinical and organisational impacts. Such
short-term appointing may reflect the business reality of
attempting to create new positions. However, as the evi-
dence mounts of benefits related to the participation of
nurses, the focus should instead be placed on how best
implement new roles or responsibilities rather than, in
effect, whether to deploy them.
Additionally, decision-makers evaluating whether to
fund and support nurse roles in AMS ought to elude po-
tential unintended consequences derived from such ap-
pointments. For example, it would be paramount for AMS
not be seen as an isolated, specialist issue that is better
handled by specialists, therefore leading to the de-skilling
[49] or disinterest from the generalist nursing workforce.
As seen in medical practice [50], non-specialist practi-
tioners are still greatly involved in, and remain respon-
sible, for the majority of AMR-related actions.
In fact, the existing narrative and experiences about
AMS nursing have mainly involved secondary care, with
a handful of experiences in community and long-term
Table 5 Examples of antimicrobial stewardship nursing posts from UK network
Domains
Antimicrobial
stewardship
nursing
posts*
Interprofessional
working+
Strategic influence-
Relation with other structures
Clinical
outcomes-
(What measure
of impact?
Process?)
Individual
identity
Funding/
Managerial
structures
Setting of
practice
(hospital,
community…)
Role
components
(clinical,
educational,
quality, policy,
managerial)
Nurse 1 Yes Relation with infection
prevention and control,
pharmacy
Evolving role focus on
Carbapanemase-producing or-
ganism screening
Process Staff Nurse Infection
Prevention &
Sepsis Team,
Nursing
Directorate
Substantive
position
Hospital Education
Nurse 2 Yes Relation with infection
prevention and control,
pharmacy
Process Staff nurse Infection
prevention and
control,
previously in
pharmacy
Substantive
position
Hospital Clinical,
education
Nurse 3 Yes Relation with infection
prevention and control,
pharmacy, antimicrobial
stewardship team, university
Clinical
outcomes,
patient
satisfaction,
process
Advanced
nurse
practitioner
Infection
Prevention and
control/
University
Substantive
position
Hospital Clinical,
education,
policy,
managerial
Nurse 4 Yes Relation with infection
prevention and control,
antimicrobial stewardship
team
Clinical
outcomes,
patient
satisfaction,
process
Lead nurse Antimicrobial
stewardship
team
Initial 1-year
funding, then
substantive
position
Community
and long-term
care facilities
Clinical,
education,
policy
Nurse 5 Yes Relation with infection
prevention and control,
antimicrobial stewardship
team
Process Staff nurse Antimicrobial
stewardship
team.
Substantive
position
Hospital Clinical
Nurse 6 Yes Relation with infection
prevention and control, and
sepsis teams, but mainly on
education for nurses
Clinical
outcome,
process
Staff nurse
based
within
pharmacy
Antimicrobial
stewardship
team
Hospital Clinical,
quality
improvement
*None of these roles exemplify the ‘horizontal’ approach theorised in the paper. +Equally, all roles explored work closely with other professions
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facilities [51]. Considering that the largest proportion of
antibiotics are prescribed in primary care and that
nurses are responsible for delivering most services, such
imbalance requires urgent attention. The current polit-
ical emphasis on universal health coverage supported by
robust nursing leadership may offer an optimal prospect
for studies of community stewardship roles.
Conclusion
In summary, pressing clinical demands imposed by anti-
microbial resistance require organisational responses
that would be remiss to ignore the contribution that
nurses can have. Optimal approaches to incorporate
such contribution remain to be agreed upon, in particu-
lar the executive and leadership rather than the clinical
facets of the nurse participation in AMS. Although solu-
tions should be context sensitive, resource dependent
and pragmatic, the horizontal model of AMS nursing
may allow for rapid system-level engagement and link-
age to existing structures such as AMS pharmacist,
which would facilitate mutual support in achieving AMS
goals.
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